NewCardio to join cardiac research consortium
NewCardio (Santa Clara, California) a cardiac diagnostic and services company, said it has become a member of the Cardiac Safety Research Consortium (CSRC).
NewCardio intends to be an active participant in CSRC efforts, by providing expertise and technology as needed, and by conducting targeted research and development projects, as such projects are reviewed and approved by the CSRC's Scientific Oversight Committee.
Branislav Vajdic, PhD, NewCardio's CEO, said, "Both NewCardio and the CSRC are firmly committed to the goals of the FDA's Critical Path Initiative, the most important of which is to develop new technology to improve cardiac safety of drugs and other medical products. We regard membership in the CSRC as an important event in advancing our mutual goals, and we look forward to active and productive participation in CSRC efforts."
Valor gets Joint Commission seal of approval
Driven by a commitment to provide safe, high-quality healthcare to U.S. veterans, Valor Healthcare (Washington) has been awarded the Joint Commission's (Oakbrook Terrace, Illinois) Gold Seal of Approval.
With this designation, Valor says that it becomes the only provider of primary care services contracted by the Department of Veterans Affairs to attain Joint Commission accreditation for all of its VA Community-Based Outpatient Clinics across the U.S.
"Valor Healthcare is very proud of this accreditation, and we look forward to working with the Joint Commission to continuously strengthen the quality and safety of healthcare offered at our clinics," said CEO Howard Lewin.
Valor Healthcare operates outpatient clinics providing primary care and mental health services to military veterans under the U.S. Department of Veterans Affairs Community-Based Outpatient Clinic Program.